JPWO2022108957A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022108957A5 JPWO2022108957A5 JP2023520376A JP2023520376A JPWO2022108957A5 JP WO2022108957 A5 JPWO2022108957 A5 JP WO2022108957A5 JP 2023520376 A JP2023520376 A JP 2023520376A JP 2023520376 A JP2023520376 A JP 2023520376A JP WO2022108957 A5 JPWO2022108957 A5 JP WO2022108957A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- wear
- processor
- event
- wearable defibrillator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000033001 locomotion Effects 0.000 claims description 187
- 238000000034 method Methods 0.000 claims description 128
- 230000008859 change Effects 0.000 claims description 65
- 238000001514 detection method Methods 0.000 claims description 37
- 230000000694 effects Effects 0.000 claims description 34
- 238000004458 analytical method Methods 0.000 claims description 32
- 230000001225 therapeutic effect Effects 0.000 claims description 28
- 238000000718 qrs complex Methods 0.000 claims description 24
- 206010003119 arrhythmia Diseases 0.000 claims description 22
- 230000004044 response Effects 0.000 claims description 17
- 230000035939 shock Effects 0.000 claims description 16
- 238000012544 monitoring process Methods 0.000 description 91
- 230000000747 cardiac effect Effects 0.000 description 84
- 230000008569 process Effects 0.000 description 50
- 230000000977 initiatory effect Effects 0.000 description 31
- 210000002216 heart Anatomy 0.000 description 30
- 210000001519 tissue Anatomy 0.000 description 29
- 239000012530 fluid Substances 0.000 description 28
- 238000002560 therapeutic procedure Methods 0.000 description 27
- 238000010586 diagram Methods 0.000 description 19
- 238000012806 monitoring device Methods 0.000 description 19
- 239000003990 capacitor Substances 0.000 description 14
- 238000004891 communication Methods 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 206010019280 Heart failures Diseases 0.000 description 12
- 239000000853 adhesive Substances 0.000 description 12
- 230000001070 adhesive effect Effects 0.000 description 12
- 238000012545 processing Methods 0.000 description 12
- 238000012790 confirmation Methods 0.000 description 11
- 230000006793 arrhythmia Effects 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 9
- 230000000875 corresponding effect Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 7
- 230000002685 pulmonary effect Effects 0.000 description 7
- 208000001871 Tachycardia Diseases 0.000 description 6
- 238000013500 data storage Methods 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 208000003663 ventricular fibrillation Diseases 0.000 description 6
- 230000036471 bradycardia Effects 0.000 description 5
- 230000009194 climbing Effects 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 238000002847 impedance measurement Methods 0.000 description 5
- 206010042772 syncope Diseases 0.000 description 5
- 230000006794 tachycardia Effects 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- 206010003658 Atrial Fibrillation Diseases 0.000 description 4
- 230000001133 acceleration Effects 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 208000006218 bradycardia Diseases 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 230000002452 interceptive effect Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 208000010496 Heart Arrest Diseases 0.000 description 3
- 206010037368 Pulmonary congestion Diseases 0.000 description 3
- 206010037423 Pulmonary oedema Diseases 0.000 description 3
- 208000009729 Ventricular Premature Complexes Diseases 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000013194 cardioversion Methods 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 230000002600 fibrillogenic effect Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 208000005333 pulmonary edema Diseases 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000002861 ventricular Effects 0.000 description 3
- 206010047302 ventricular tachycardia Diseases 0.000 description 3
- 208000007944 Nodular Nonsuppurative Panniculitis Diseases 0.000 description 2
- 206010058151 Pulseless electrical activity Diseases 0.000 description 2
- 206010041235 Snoring Diseases 0.000 description 2
- 230000001594 aberrant effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 206010061592 cardiac fibrillation Diseases 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 229910001416 lithium ion Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- -1 patient temperature Chemical compound 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 201000002859 sleep apnea Diseases 0.000 description 2
- 238000010183 spectrum analysis Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 206010003130 Arrhythmia supraventricular Diseases 0.000 description 1
- 206010003662 Atrial flutter Diseases 0.000 description 1
- 206010003671 Atrioventricular Block Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 208000004301 Sinus Arrhythmia Diseases 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- OJIJEKBXJYRIBZ-UHFFFAOYSA-N cadmium nickel Chemical compound [Ni].[Cd] OJIJEKBXJYRIBZ-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000005189 cardiac health Effects 0.000 description 1
- 210000004903 cardiac system Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000009091 contractile dysfunction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000001862 defibrillatory effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 239000013315 hypercross-linked polymer Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000002646 transcutaneous electrical nerve stimulation Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/951,246 | 2020-11-18 | ||
| US16/951,246 US11865350B2 (en) | 2020-11-18 | 2020-11-18 | Systems and methods of monitoring wear compliance of a patient wearing an ambulatory medical device |
| PCT/US2021/059604 WO2022108957A1 (en) | 2020-11-18 | 2021-11-17 | Systems and methods of monitoring wear compliance of a patient wearing an ambulatory medical device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550683A JP2023550683A (ja) | 2023-12-05 |
| JPWO2022108957A5 true JPWO2022108957A5 (enrdf_load_stackoverflow) | 2024-11-20 |
Family
ID=78844985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023520376A Pending JP2023550683A (ja) | 2020-11-18 | 2021-11-17 | 携帯型医療デバイスを装着している患者の装着コンプライアンスをモニタリングするシステムおよび方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11865350B2 (enrdf_load_stackoverflow) |
| EP (1) | EP4247486A1 (enrdf_load_stackoverflow) |
| JP (1) | JP2023550683A (enrdf_load_stackoverflow) |
| CN (1) | CN116457057A (enrdf_load_stackoverflow) |
| WO (1) | WO2022108957A1 (enrdf_load_stackoverflow) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4475757A1 (en) * | 2022-02-07 | 2024-12-18 | Zoll Medical Corporation | Patient engagement for wearable medical devices |
| US20240090854A1 (en) * | 2022-09-16 | 2024-03-21 | West Affum Holdings Corp. | Wearable medical device system with caregiver notifications |
| CN115607270B (zh) * | 2022-10-28 | 2025-04-29 | 深圳由莱智能电子有限公司 | 美容控制方法及装置、美容设备与可读存储介质 |
| EP4634780A1 (en) * | 2022-12-15 | 2025-10-22 | LifeSignals, Inc. | Systems and methods for optimizing health care resources and patient monitoring |
| JP2024157309A (ja) * | 2023-04-25 | 2024-11-07 | 新東工業株式会社 | 教師データ生成装置、教師データ生成方法、モデル生成装置、推定装置、及びプログラム |
| WO2025054443A1 (en) * | 2023-09-06 | 2025-03-13 | Georgia Tech Research Corporation | Deterministic seismocardiogram analysis for monitoring and diagnosis of valvular heart disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10449370B2 (en) * | 2014-05-13 | 2019-10-22 | West Affum Holdings Corp. | Network-accessible data about patient with wearable cardiac defibrillator system |
| US9839356B2 (en) | 2015-07-07 | 2017-12-12 | Zoll Medical Corporation | Systems and methods for communicating data |
| US11154228B2 (en) | 2015-08-31 | 2021-10-26 | Zoll Medical Corporation | Electrode use indication |
| US20170181703A1 (en) * | 2015-12-29 | 2017-06-29 | Zoll Medical Corporation | Monitoring A Garment |
| US11709747B2 (en) * | 2016-01-08 | 2023-07-25 | Zoll Medical Corporation | Patient assurance system and method |
| US10426342B2 (en) * | 2016-03-31 | 2019-10-01 | Zoll Medical Corporation | Remote access for ambulatory medical device |
| US11154230B2 (en) * | 2017-01-05 | 2021-10-26 | West Affum Holdings Corp. | Wearable cardioverter defibrillator having reduced noise prompts |
| JP2018139761A (ja) * | 2017-02-27 | 2018-09-13 | 株式会社テクノ・コモンズ | 生体信号計測装置 |
| US11160972B2 (en) | 2018-03-30 | 2021-11-02 | Zoll Medical Corporation | Garments for wearable cardiac monitoring and treatment devices |
-
2020
- 2020-11-18 US US16/951,246 patent/US11865350B2/en active Active
-
2021
- 2021-11-17 CN CN202180076551.4A patent/CN116457057A/zh active Pending
- 2021-11-17 WO PCT/US2021/059604 patent/WO2022108957A1/en not_active Ceased
- 2021-11-17 EP EP21824202.2A patent/EP4247486A1/en active Pending
- 2021-11-17 JP JP2023520376A patent/JP2023550683A/ja active Pending
-
2023
- 2023-11-20 US US18/513,852 patent/US20240091544A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12161875B2 (en) | Wearable medical device for continuous heart monitoring with intermittent additional signal data provided via one or more touch-sensitive electrodes | |
| US11844620B2 (en) | Configuring a cardiac monitoring device | |
| US20240091544A1 (en) | Systems and methods of monitoring wear compliance of a patient wearing an ambulatory medical device | |
| US12420107B2 (en) | Wearable cardiac device to monitor physiological response to activity | |
| US10470702B2 (en) | Assigning zone-based rankings and actions | |
| US12167916B2 (en) | Ambulatory medical device including a digital front-end | |
| US12064640B2 (en) | Response mechanisms | |
| EP4547326A1 (en) | Double sequential and multiple vector defibrillation for wearable cardioverter defibrillators | |
| US20250195901A1 (en) | Baselining therapy energy for wearable cardiac treatment devices | |
| US20240245354A1 (en) | Remote cardiotoxicity monitoring | |
| JPWO2022108957A5 (enrdf_load_stackoverflow) | ||
| CN115426952B (zh) | 确定可穿戴式医疗装置患者中的不同睡眠阶段 | |
| US12251226B2 (en) | Ambulatory medical device having sensors with localized driven grounds | |
| US20240306911A1 (en) | Minimum morphological region analysis | |
| US20250204836A1 (en) | Processing Short Term ECG-Based Noise Artifacts in Wearable Cardiac Systems | |
| US20230397872A1 (en) | Systems and methods for determining electrode-skin contact using signal undersampling | |
| WO2025111300A1 (en) | Tachyarrhythmia discrimination |